Lipid Nanoparticle Technology to Enable Nucleic Acid Therapeutics and Vaccines
Wednesday, July 28, 12PM - 4PM & 5PM - 9PM EDT
|
Sponsored By:
|
|
|
|
Nucleic acid-based therapeutics have the potential to treat or prevent many important diseases. Delivery science to ensure reproducible and efficient intracellular delivery to specific tissues is core to their success. Currently there are only 3 nucleic acid-based products using lipid nanoparticles as the delivery system. Goals of this workshop are to outline some of the current status of nucleic acid-based therapeutics and their delivery systems, review some of the delivery approaches and gaps, as well as discuss some of the pharmaceutical development challenges and solutions in terms of formulation and process optimization and advanced analytical characterization.
This is workshop is focused on clinical translation with speakers who have experience in different phases of the translation (design, formulation/process scale up, analytical characterization, regulatory science) including challenges and solutions of LNP systems. It will also outline the gaps and the importance of delivery science and designing delivery systems with the "end game" in mind i.e. an efficient robust product that meets the target product profile The target audience are world leaders, academics, postdocs, and trainees from academia and industry.
It will consist of several talks from leading experts related to different aspects of factors related to successful clinical translation and product design with time for Q & A. Panel discussions at the end of each workshop part will enable the participants to interact and have an in-depth discussion with world-leaders in the field.
This is workshop is focused on clinical translation with speakers who have experience in different phases of the translation (design, formulation/process scale up, analytical characterization, regulatory science) including challenges and solutions of LNP systems. It will also outline the gaps and the importance of delivery science and designing delivery systems with the "end game" in mind i.e. an efficient robust product that meets the target product profile The target audience are world leaders, academics, postdocs, and trainees from academia and industry.
It will consist of several talks from leading experts related to different aspects of factors related to successful clinical translation and product design with time for Q & A. Panel discussions at the end of each workshop part will enable the participants to interact and have an in-depth discussion with world-leaders in the field.
